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Background: The CaSR senses alterations in 
extracellular Ca2+ mainly through its extracellular 
domain. 
Results: Interactions of ligands with the CaSR 
were characterized using purified ECD and 
biophysical techniques.  
Conclusion: Ca2+ and L-Phe bind to both the 
complex and high mannose forms of the CaSR’s 
ECDs and increase binding affinities for each 
other. 
Significance: Our findings will provide an 
essential tool for future structural studies in 
GPCRs. 
ABSTRACT 
Numerous in vivo functional studies have 
indicated that the dimeric extracellular domain 
(ECD) of the CaSR plays a crucial role in 
regulating Ca2+ homeostasis by sensing Ca2+ and 
L-Phe. However, direct interaction of Ca2+ and 
Phe with the receptor’s ECD and the resultant 
impact on its structure and associated 
conformational changes have been hampered by 
the large size of the ECD, its high degree of 
glycosylation, and the lack of biophysical methods 
to monitor weak interactions in solution. In the 
present study, we purified the glycosylated 
extracellular domain of CaSR (ECD) (residues 
20~612), containing either complex or high 
mannose N-glycan structures depending on the 
host cell line employed for recombinant 
expression. Both glycosylated forms of the CaSR 
ECD were purified as dimers and exhibit similar 
secondary structures with ~50% -helix, ~20% -
sheet content and a well buried Trp environment. 
Using various spectroscopic methods, we have 
shown that both protein variants bind Ca2+ with a 
Kd of 3.0~5.0 mM. The local conformational 
changes of the proteins induced by their 
interactions with Ca2+ were visualized by NMR 
with specific 15N Phe-labeled forms of the ECD. 
Saturation transfer difference (STD) NMR 
approaches demonstrated for the first time a direct 
interaction between the CaSR ECD and L-Phe. We 
further demonstrated that L-Phe increases the 
binding affinity of the CaSR ECD for Ca2+. Our 
findings provide new insights into the mechanisms 
by which Ca2+ and amino acids regulate the CaSR 
and may pave the way for exploration of the 
structural properties of CaSR and other members 
of family C of the GPCR superfamily.  
 
INTRODUCTION  
The Calcium-Sensing Receptor (CaSR) is a 
seven transmembrane protein that belongs to 
family C of the G protein-coupled receptor 
superfamily (1). The CaSR is named after its 
major function in regulating calcium homeostasis 
in the body. Its predominant expression in 
parathyroid and kidney cells allows this receptor 
to modulate parathyroid hormone (PTH) secretion 
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 2 
as well as renal calcium reabsorption (2-5). The 
CaSR is also widely expressed in other sites 
including the gastrointestinal system (6), the 
central nervous system (7), breast (8), and bone 
(9), among others, where it plays crucial roles in 
physiological and pathological functions, 
including cell proliferation, tissue differentiation 
and cancer development (10). In addition to its 
primary agonist, Ca2+, the CaSR can also respond 
to various other stimuli, including other cations 
(11), amino acids (7,12), polyamines (13), and 
polypeptides (14). L-amino acids, especially 
aromatic amino acids (e.g. L-Phenylalanine), are 
thought to enhance the sensitivity of CaSR to the 
extracellular calcium concentration ([Ca2+]o) by 
interacting with the receptor’s extracellular 
domain (ECD) as demonstrated in several in vivo 
studies using HEK293 cells transfected with the 
CaSR (12,15). Branched-chain amino acids (e.g. 
L-Aspartic acid, L-Lysine etc.) are less effective 
than aromatic amino acids (12). This could be one 
potential explanation for how dietary protein 
modulates [Ca2+]o homeostasis in normal 
individuals as well as in patients with chronic 
renal failure (6,16). 
Like many membrane receptors, the CaSR is 
heavily glycosylated with 11 highly conserved 
putative N-linked glycosylation sites (Asn-Xaa-
Ser/Thr). These glycosylation sites are considered 
to be critical for the CaSR’s cell surface 
expression (17). Membrane CaSR functions as a 
dimer and is comprised of the three major 
structural domains of the GPCR family C: an 
extracellular domain (ECD) that covers from 20 to 
612 amino acids (2); a seven-transmembrane 
domain (613-862) (18) and an intracellular tail of 
216 amino acids (19), which participates in 
conveying extracellular stimuli into intracellular 
signaling pathways. While efforts to obtain pure 
ECD protein have been reported by two 
independent groups (20,21) using an HEK293 cell 
line stably transfected with the CaSR ECD and 
insect cells expressing the CaSR ECD, 
respectively, the structure of CaSR remains 
undetermined to date.   
Our lab has built an homology model of the 
CaSR ECD based on the crystal structure of 
metabotropic glutamate receptor 1 (mGluR1) (22-
24) and identified five potential Ca2+-binding 
pockets using computational algorithms developed 
in our lab (22,23). Using site-directed mutagenesis 
and intracellular Ca2+ readout, we further verified 
the roles of those predicted Ca2+-binding sites and 
an L-Phe-binding site in regulating functional 
activities of the receptor (24). 
Despite extensive functional studies on the 
CaSR by different groups (12,15,25-27), how 
calcium and L-Phe directly interact with the 
extracellular domain is still under debate due to 
the lack of structural information as well as 
absence of  binding assays for sites with weak 
binding affinities (0.1-30 mM). One of several 
challenges is related to the high level of 
glycosylation in the CaSR ECD that not only 
increases the size of the protein but introduces 
structural heterogeneity into the entire system. 
Direct visualization of interactions of weak 
binding ligands with a receptor’s ECD may also be 
hampered by the high off rate associated with 
weak binding. For example, Ca2+-binding sites of 
mGluRs are not visible in all reported X-ray 
structures (28). Direct monitoring of ligands (Ca2+ 
and L-Phe) and protein interactions in solution and 
characterization of the biophysical properties of 
such a large protein as well as collection of 
structurally related information using 
spectroscopic methods also requires a large 
amount of homogenous native protein.   
In the present study, we report our progress in 
expression and purification of the glycosylated 
extracellular domain of CaSR (ECD) (residues 
20~612) using two mammalian expression 
systems that generate distinct glycosylated 
products, wild type 293-F cells or the HEK293S 
(GnTI-) cell line. The former wild type cell line 
generates recombinant products harboring 
heterogeneous complex type N-glycans. In 
contrast, the second HEK293S (GnTI-) cell line 
lacks the enzyme GlcNAc transferase I (GnTI) 
(29), an enzyme required for the first step in the 
conversion of high mannose N-glycans into 
complex and hybrid structures (30,31). The  
HEK293S (GnTI-) cells are unable to synthesize 
complex and hybrid N-glycans and instead 
produce oligosaccharides containing  a more 
homogeneous collection of structures based on 
Man5GlcNAc2-Asn (32).  
Here, a soluble, secreted form of the CaSR ECD 
was generated in 293-F or HEK293S (GnTI-) cells 
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 3 
by transient transfection, and the protein was 
further purified by affinity chromatography. The 
biophysical properties of the native CaSR ECDs 
were characterized using fluorescence titration 
spectroscopy, circular dichroism, and NMR 
spectroscopy. We demonstrate herein that the 
ECD of CaSR directly interacts with Ca2+ and L-
Phe, with binding affinities in the mM range for 
both.  
MATERIALS AND METHODS 
Construct CaSR-ECD cDNA: For engineering of 
the CaSR-ECD, the sequence Tyr20-Phe612 was 
cloned from CaSR-pCDNA 3.1(+) by standard 
PCR methods using the following 5’ primer 
(CCGGAAT TCTACGGGCCAGACCAGCGAG 
CCCAA) and 3’ primer (CCCAAGCTTTT 
AAAAGGGCTCCGTCCACGACAGAAACT). 
The cloned sequence was then inserted into the 
plasmid pGEn1 between the EcoRI and HindIII 
restriction sites. The engineered protein contains a 
signal peptide (MRLLTALFAYFIVALI LAFSVS 
AKS) followed by a His-tag and a StrepII tag at 
the N-terminus. A flag-tag site was inserted 
between residues D371 and T372. The plasmid 
constructs were confirmed by DNA sequencing 
(GENEWIZ, South Plainfield, NJ).   
Protein expression and purification: For 
mammalian expression, either wild type HEK293 
cells in suspension culture (FreeStyle 293-F cells, 
Life Technologies, Grand Island, NY) or mutant 
HEK293S GnTI- cells (29) (ATCC cat. no. CRL-
3022) were transfected with pGEn1-hCaSR-ECD 
plasmid using the polyethyleneimine (PEI) method 
as previously described (33). The hCaSR-ECD 
was secreted into the culture media and harvested 
after centrifugation 3 times at 1500xg for 10 min. 
The supernatant was diluted with the following 
buffer, 75 mM Tris HCl, 360 mM NaCl, pH 8.0, at 
a ratio of 1:2 and further filtered through a 0.45 
m filter (Millipore, Billerica, MA). The filtered 
medium was applied to a 16/10 HisPrep HP 
column (GE Healthcare) pre-equilibrated with 
Buffer A (50 mM Tris HCl, 150 mM NaCl, 20 
mM imidazole), and a linear segmented gradient 
of 0–100% Buffer B (50 mM Tris HCl, 500 mM 
NaCl, and 500 mM imidizole, pH 7.4) was run to 
elute the protein. The enriched protein was further 
treated with a desalting column (GE HiTrap) using 
10 mM Tris Buffer (pH 7.4). The concentrations 
of hCaSR-ECD were determined using the BioRad 
protein assay.  
Lectin Agarose Binding Assay: Fractions 
containing the CaSR ECD following HisPrep 
chromatography were mixed with 30 L of RCA-1 
lectin agarose (Vector Lab, Burlingame, CA) for 
overnight incubation at 4℃ followed by washing 
with PBS. The ECD protein was eluted using 0.2 
M galactose. The eluted fractions were analyzed 
by Western blot, using an anti-flag antibody. 
Deglycosylation reactions: Triton X-100 was 
added to heat- and SDS-denatured, purified ECD 
protein (20 g) at a final concentration of 2% 
before the protein was subjected to the Peptide -N-
Glycosidase F (PNGase F) deglycosylation 
procedure. Approximately 1.4 units of PNGase F 
were added per microgram of purified protein and 
incubated for 2 h at 37℃ . The deglycosylated 
samples were further analyzed by Western blot 
using the anti-Flag antibody. For Endoglycosidase 
F1 (Endo F1) enzyme treatment under native 
conditions, purified CaSR-ECD protein generated 
in HEK293S (GnTI-) cells was taken directly from 
the appropriate FPLC fractions and incubated with 
Endo F1 at a mass ratio 1:3 in 10 mM Tris buffer, 
pH 7.4 for overnight incubation at 4 ℃.  
Circular Dichroism: The circular dichroism 
spectra were recorded from 190 to 260 nm on a 
Jasco-810 spectropolarimeter purged by N2 and 
equipped with a temperature control system (CTC-
345). Spectral and temperature-dependent 
measurements were performed at a bandwidth of 2 
nm using a U-type quartz cell of path length 0.1 
mm with protein concentrations ranging from 8 to 
10 M in 10 mM Tris-HCl, pH 7.4. Five spectra 
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 4 
were recorded for each sample at a scan rate of 
50nm/min and response time of 1s. The 
continuous temperature dependence of the 
ellipticity at 222 nm was measured using a scan 
rate of 50 C/h and a delay time of 100 s. The 
cuvette was sealed with parafilm to prevent 
solvent evaporation. 
The spectra were deconvoluted using the Selcon 
method after subtracting the spectrum of the buffer 
as the blank, and the CD data are depicted in units 
of molar ellipticity per residue. The melting curve 
was fitted using the equation  
∆S = ∆Smax/(1 + e(Tm-T)/k)   (Eq1) 
to obtain the thermal transition point, where ∆S 
and ∆Smax are the signal changes at each data point 
and the final point; Tm and T are the transition 
temperature and experimental temperature, 
respectively. k is a transition rate that defines how 
fast the temperature-induced change occurs, which 
is represented by the slope of the transition phase 
in the fitting curve. A smaller k results in a sharper 
transition (34).  
Fluorescence Spectroscopy: A Photon 
Technology International (Edison, New Jersey) 
Lifetime Fluorimeter was used to record the 
fluorescence spectra at room temperature using a 
1-cm path length cell. Intrinsic tryptophan 
emission spectra were recorded from 300 to 400 
nm with an excitation wavelength at 282 nm. The 
slit widths were set at 0.3~1 nm for excitation and 
1.0~2.0 nm for emission, respectively. The 
calcium titration was performed in a buffer system 
(10 mM HEPES, 120 mM NaCl and 10 mM KCl, 
pH=7.2) with protein concentrations of 1.5~2.0 
M by adding a known amount of CaCl2. The free 
Ca2+ concentration in the buffers used in this 
study, which were not treated with Chelex-100, 
has been measured to be <10 M using BAPTA, a 
calcium-specific chelator. Our previous studies 
showed that the Ca2+ dissociation constant was 
determined to be ∼0.7 mM for the “high affinity” 
Ca2+-binding site (22). Given this fact, the 
background Ca2+ concentration may be negligible. 
For the Tyr/Trp-sensitized Tb3+ fluorescence 
energy transfer (Tb3+-FRET) assay, protein 
samples (1.5~2.0 M) were in 20 mM PIPES-10 
mM KCl at pH 6.8. The emission spectra were 
collected from 500-600 nm with the excitation at 
282 nm. The slit widths for excitation and 
emission were set at 1 nm and 3 nm, respectively. 
Secondary Rayleigh scattering was circumvented 
by using a glass filter with a cutoff of 320 nm. The 
Tb3+ titration was performed by adding various 
volumes of Tb3+ stock solutions (1 mM) stepwise 
into the cuvettes. The Ca2+ -Tb3+ competition 
experiments were performed in solutions 
containing 30~50 M Tb3+ and 2 M protein as 
the starting point. The stock solutions of 100 mM 
or 1 M CaCl2 with the same concentration of Tb3+ 
were gradually added into the mixture. The 
background fluorescence intensity was subtracted 
using logarithmic fitting and the Tb3+-binding 
affinity of the protein was calculated by fitting 
normalized fluorescence intensity data using the 
Hill equation 
nn
d
n
MK
M
S
][
][

  (Eq.2) 
where ΔS is the total signal change in the 
equation, Kd is the apparent binding affinity, n is 
the Hill coefficient, and [M] is the free metal 
concentration.  
The Ca2+ competition data were first analyzed to 
derive the apparent dissociation constant by 
Equation 3. By assuming that the sample is 
saturated with Tb3+ at the starting point of the 
competition, the Ca2+-binding affinity is further 
obtained by using the equation, 
][
,
,
,
TbK
K
KK
Tbd
Tbd
appCad

 (Eq. 3) 
where Kd,Ca and Kd,Tb are the dissociation constants 
of Ca2+ and Tb3+, respectively. Kapp is the apparent 
dissociation constant. 
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 5 
ANS-Binding Measurements: For the ANS (8-
anilino-1-naphthalenesulfonic acid) binding assay, 
protein samples were incubated with a buffer 
containing 40 M ANS, 50 mM Tris-HCl and 100 
mM KCl (pH 7.4) with either 5 mM EGTA or 3 
mM Ca2+ at 4C in the dark for 1 h with constant 
rotation prior to measurements. The excitation 
wavelength was set at 370 nm, and the emission 
spectra were acquired from 400 to 600 nm. For the 
Ca2+ titration, the protein concentration was 2.0 
M and the Ca2+ concentration was varied from 0 
to 30 mM in 20 mM Tris-HCl, 50 mM KCl, pH 
7.4. 
NMR Spectroscopy of CaSR ECD: All NMR 
spectroscopy experiments were performed on a 
VARIAN Inova 800 MHz spectrometer equipped 
with the cryogenic HCN probe at 37 oC. The 
CaSR-ECD was prepared in 10 mM Tris, pH 7.4, 
20% (v/v) D2O for NMR experiments. For the 
calcium titration, both one dimensional 1H and 
two-dimensional 1H-15N NMR spectra of 15N-Phe 
selectively labeled CaSR-ECD in the presence of 
0, 1, 3, 5 and 10 mM Ca2+ were collected and 
processed by MestReNova (35) and NMRpipe 
(36), respectively. The 1H-15N-HSQC data were 
analyzed by Sparky (37) and the chemical shift 
perturbations were calculated using the equation 
    ]07.0[5.0 21521 NHav   (Eq.4)  
where ∆δav is the chemical shift perturbations of 
the 1H-15N spectra, ∆δ is the chemical shifts for 1H 
or15N (38).  
 
For STD-NMR, 20 μM CaSR-ECD expressed in 
HEK293S (GnTI-) cells was prepared in 10 mM 
Tris in D2O, pD 7.8. The blank experiment without 
protein was performed to examine the absence of 
direct saturation of L-Phe in certain on-resonance 
frequencies.  Saturation transfer from the protein 
to L-Phe was achieved by irradiating at -1 ppm 
with a duration of 3 s. The reference spectra were 
obtained by irradiating at 30 ppm. The STD-NMR 
data were processed and analyzed by MestReNova 
and the STD amplification factor was calculated 
by using the equation  
][
][
P
L
I
II
AFSTD T
ref
satref


  (Eq.5)  
where AF stands for amplification factor.  
The Kd was determined using the equation 
][
][
LK
L
AFSTD
D
std



, (Eq. 6) 
where αstd is the amplification when it is saturated 
by a ligand (39). 
Statistics: The data are presented as means ± SE of 
three independent experiments. Statistical analyses 
were carried out using the unpaired Student’s t-test 
when two groups were compared. A P value of < 
0.05 was considered to indicate a statistically 
significant difference. 
RESULTS 
The CaSR ECD forms a dimer in culture 
medium: Wild type 293-F cells or HEK293S 
(GnTI-) cells were transiently transfected with 
engineered CaSR ECD cDNA (Fig.1a). The signal 
peptide at the N-terminus led to secretion of the 
CaSR ECD (Fig. 1b), which is predicted to have 
five potential Ca2+-binding sites based on the 
homology model of metabotropic glutamate 
receptor 1 (mGluR1) (Fig. 1c), into the culture 
medium. (22). These His-tagged CaSR ECDs were 
efficiently separated from other proteins with a 
HisPrep column using an imidazole gradient (Fig. 
2 a and b).  The fractions containing CaSR ECD 
were collected and separated by SDS-PAGE under 
reducing conditions (Fig. 2 a and b). Immunoblots 
were further applied to visualize the CaSR in the 
samples using specific anti-CaSR antibody. As 
shown in Fig. 2 (panels c-e) CaSR ECD from 293-
F cells exhibited a diffuse band in the range from 
~100 to ~130 kDa suggesting heterogeneity of 
glycosylation while the GnTI- CaSR has a single 
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 6 
sharp band with a molecular weight of 
approximately 95 kDa. The non-reducing samples 
from the 293-F cells and the GnTI- cells 
expressing the CaSR ECD have molecular weights 
at around 240 kDa and 200 kDa, respectively, 
corresponding to the respective calculated 
molecular weights of the dimerized forms of the 
receptor extracellular domain.      
The secreted CaSR ECD is glycosylated: In order 
to verify that the secreted 293-F CaSR ECD is 
glycosylated, Ricinus Communis Agglutinin I 
(RCA I) agarose beads, which preferentially bind 
to complex oligosaccharides, were incubated with 
the purified protein. The CaSR ECD expressed in 
293-F cells interacted with the RCA I beads (Fig. 
2f) and high concentrations of galactose (200 mM) 
competed with the glycoprotein for interaction 
with the lectin agarose beads. Peptide N-
glycosidase F (PNGase F) cleaves high mannose, 
hybrid, and complex oligosaccharides from N-
linked glycoproteins between the innermost 
acetylglucosamine (GlcNAc) and the underlying 
asparagine residues (40). Cleavage of denatured 
CaSR ECD generated in 293-F cells with PNGase 
F resulted in a decrease from ~100 to ~ 80 kDa 
(Fig. 2g) indicating that the protein is highly 
glycosylated. Similarly, Endo F1 cleaves between 
the two core GlcNAc residues on high mannose, 
but not hybrid or complex type N-glycans to leave 
a single GlcNAc residue attached to the 
polypeptide (41). Cleavage of the CaSR ECD 
derived from HEK293S (GnTI-) cells with Endo 
F1 under non-denaturing conditions resulted in the 
production of a lower molecular weight band at ~ 
87 kDa in the reducing SDS-Page gels, which 
indicates that this recombinant product contains 
exclusively high mannose N-glycans.  
Measuring the secondary and tertiary structure 
of CaSR ECDs: In order to analyze the secondary 
structures of the purified CaSR ECDs, circular 
dichroism measurements were performed. Typical 
far-UV CD spectra for both protein preparations 
are shown in Fig. 3. Analysis of all the spectra 
indicated that the purified 293-F and GnTI- CaSR 
ECD shared similar secondary structures with  
helical contents of 52-58% and -sheet contents of 
17-25%. The addition of calcium produced 
minimal changes in the spectra of either the 293-F 
CaSR ECD or the GnTI- CaSR ECD (Fig. 3a and 
b, Table 1).   
The tryptophan environment and the packing of 
proteins can be monitored by analyzing the 
intrinsic tryptophan emission spectra at 300 to 400 
nm using an excitation wavelength of 282 nm, 
since there are twelve tryptophan (Trp) residues in 
the ECD. The emission spectrum of free Trp has a 
peak at around 350 nm. The emission peak 
undergoes a blue-shift if the tryptophan is 
embedded in a hydrophobic environment. All the 
Trp emission spectra of the various forms of the 
CaSR ECD showed a peak at around 334 nm 
indicating that the proteins have retained their 
native-like structure (Fig. 4).  
The Stability of CaSR ECDs: The stabilities of the 
purified ECDs were further investigated using 
immunoblots. Samples of the CaSR ECD from 
both 293-F and the HEK293S (GnTI-) cells were 
kept at room temperature continuously for seven 
days without any appreciable loss of protein from 
degradation as assessed by Western blots (Fig. 3 d 
and e). The proteins were subjected to stepwise 
increases in temperature to measure their thermal 
stability. The molar ellipticity signal was 
monitored from 4~ to 95 C at 222 nm. As shown 
in Fig. 3c, the 293-F CaSR ECD demonstrated 
extraordinary thermal stability as the signal at the 
given wavelength did not change in this 
temperature range. The high mannose form of the 
CaSR ECD from HEK293 (GnTI-) cells appeared 
to be slightly less stable with an increase in 
ellipticity at > 92C. The cooperative unfolding 
transition further support the formation of a well-
packed core for the CaSR ECD as revealed by Trp 
emission fluorescence. The effect of calcium on 
the thermal stability was not determined due to 
 at G
EO
RG
IA
 STA
TE U
N
IV
 on Septem
ber 23, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 
 
 7 
precipitation of the protein at high temperature in 
the presence of calcium.  
The effect of calcium-binding on CaSR ECDs: 
As shown in Fig. 3 a and b, the addition of Ca2+ 
leads to small changes in the secondary structure 
of CaSR ECDs as revealed by CD. However, the 
addition of Ca2+ could possibly induce more 
significant local conformational changes as probed 
by various spectroscopic methods.  
 
Ca2+-induced conformational changes were probed 
by both Trp and ANS emission spectra (Fig. 4 and 
5). Binding of Ca2+ resulted in a 2~3 nm blue shift 
of the emission maxima of the Trp fluorescence 
spectra of both the 293-F CaSR ECD and the 
HEK293S (GnTI-) CaSR ECD. Furthermore, a 
20% decrease in the Trp fluorescence intensity of 
the CaSR ECD expressed in 293-F cells was 
observed upon addition of saturating amounts of 
Ca2+, whilst 14% decreases in the signal were 
shown in the case of the CaSR ECD expressed in 
HEK293S (GnTI-) cells. The Kd of Ca2+ 
determined by Trp florescence changes of CaSR 
was 4.9 ± 0.3 mM and 5.4 ± 0.2 mM for 293-F 
CaSR ECD and GnTI- CaSR ECD, respectively. 
The Hill coefficients obtained from the Trp 
fluorescence spectra were 1.3 ± 0.1 for 293-F 
CaSR ECD and 1.1 ± 0.1 for GnTI- CaSR ECD, 
indicating the two protein variants differing in 
glycosylation may share similar Ca2+ binding 
capability (Fig. 4 and Table 2), although the Hill 
number obtained by this method is substantially 
lower than that obtained by functional assays (~3-
4) 
ANS, a fluorescence probe extensively used for 
the detection and analysis of protein 
conformational changes, was applied to the study 
of the two proteins (42). Fig. 5 shows that addition 
of either form of the CaSR ECD resulted in a 30 
nm blue shift of the spectra of ANS dye from 500 
to 466 nm and a 10-fold increase in fluorescence 
intensity (Fig. 5). Such a blue shift of the emission 
spectrum and increase of the fluorescence intensity 
suggest that the fluorophore is located in less polar 
media (43). 
Interestingly, Fig. 5 shows that Ca2+ also induced 
greater exposure to solvent of more hydrophobic 
regions in the complex oligosaccharide form of the 
ECD (293-F CaSR ECD) that was indicated by a 
25% increase in the fluorescence signal intensity 
contrasting with the 10% change in intensity for 
the high mannose glycosylated form of the ECD 
expressed in HEK293S (GnTI-) cells. The 
calcium-induced ANS florescence signal at 466 
nm was also fitted by the Hill equation. The 293-F 
CaSR ECD had a Kd of 3.8 ± 0.2 mM while GnTI- 
CaSR ECD had a Kd value at 3.2 ± 0.1 mM. Their 
corresponding Hill coefficients calculated from the 
Ca2+-ANS titration curves were 2.6 ± 0.2 and 2.3 ± 
0.2 respectively (Fig. 5 & Table 2). This approach, 
therefore, may sample more Ca2+-binding sites 
than the use of Trp fluorescence. 
Due to their similarities in ionic radii and 
coordination chemistries, Tb3+ has been commonly 
used to probe Ca2+-binding sites as a trivalent Ca2+ 
analogue. There are 12 Trp residues on the CaSR 
ECDs. According to the model structure of the 
CaSR ECD, several Trp residues are within 10 Å 
of these potential calcium-binding pockets, thus 
enabling aromatic residue-sensitized Tb3+-
luminescence resonance energy transfer (LRET).  
Fig. 6 shows that titration of Tb3+ into a solution 
containing either of the two ECDs showed an 
enhanced LRET (Fig. 6), consistent with Tb3+-
binding in close proximity to the predicted 
calcium-binding sites. On the other hand, addition 
of calcium to the Tb3+-bound ECDs resulted in a 
decrease of the fluorescence signal indicating 
competition between the two ions (Fig. 7). The 
Tb3+-binding affinity for 293-F CaSR ECD was 
about 36.6 ± 0.4 M with a Hill coefficient at 1.2 
± 0.1 suggesting a 1:1 binding mode of the 
interaction between Tb3+ and its binding pockets 
(Fig. 6). In terms of GnTI- CaSR ECD, the Kd for 
Tb3+ was 31.8 ± 0.3 M which is comparable with 
the 293-F CaSR ECD. The Ca2+-Tb3+ competition 
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assay yielded apparent dissociation constants for 
the ECDs, from which the binding constants for 
calcium can be deduced (Fig.7). The Ca2+-binding 
dissociation constants calculated from Ca2+-Tb3+ 
competition assay using equation 2 for the 293-F 
CaSR ECD and the GnTI- CaSR ECD were 3.7 ± 
0.2 mM and 2.4 ± 0.2 mM, respectively, which are 
comparable to the Kd calculated from Ca2+-
induced changes in native Trp signals as well as 
the ANS spectra. 
Perturbations of NMR chemical shift can be used 
to monitor the interactions between metals and the 
protein. To ascertain whether those perturbations 
are occurring at the interacting interface of the 
ECD with its large protein size, we achieved 
specifically labeling of Phe residues with 15N in 
both mammalian expressed proteins with a yield 
of 4-5 mg/L and 0.9-1.0 mg/L for 293F cells and 
GnTI- cells, respectively (MATERIALS AND 
METHODS). Both of the 15Phe-labeled proteins 
exhibited identical native dimer conformations 
similar to the unlabeled proteins (Fig. 2).  
The low resolution of the peaks didn’t permit 
assignment of the chemical shifts of the high 
mannose form of the protein. Ca2+-induced protein 
conformational change could be observed in the 
one-dimensional (1D) NMR when Ca2+ was 
titrated into the 15N L-Phe-labeled 293-F CaSR 
ECD (Fig. 8). The Ca2+ induced changes in two-
dimensional (2D) NMR could be evaluated using 
293-F CaSR ECD.  As shown in Fig. 9, during the 
titration with Ca2+, a progressive disappearance of 
the amide signals at 8.05 ppm was accompanied 
by the concomitant emergence of a new set of 
peaks at 7.85 ppm as well as a chemical shift 
between the amide signals at 7.95 ppm and 8.21 
ppm (Fig. 9a, b, and c) indicating a complex 
response to Ca2+-binding. The low expression 
yield and dispersion of the 15N Phe-labeled GnTI- 
CaSR ECD with high mannose form prevented us 
from further studies using NMR. 
 The chemical shifts of the peaks were further 
plotted as calcium concentration-response curves 
as shown in Fig. 9 (right panel).  The calcium-
induced chemical shift changes at 8.18 and 7.96 
ppm with intermediate and fast exchanges in Fig. 
9b could be well-fitted by the Hill equation 
assuming formation of a 1:1 ligand-protein 
complex with a Kd of 1.1 mM (Fig. 9 upper right 
panel). On other hand, analysis of the peaks in Fig. 
9c suggests a slow exchange process in which the 
exchange rates of the bound and unbound 
conformations were slower than the change in 
amide chemical shifts in frequency units. The Ca2+ 
concentration-response curve with a Kd at 2.5 mM 
and a Hill coefficient of 2.5 suggesting more than 
one ligand-binding site, and similar to the values 
obtained using the ANS assay 
L-Phe modulated the binding of Ca2+ to CaSR by 
directly interacting with the CaSR ECDs.  Direct 
evidence demonstrating the interaction between 
this amino acid with the CaSR ECD is difficult to 
achieve due to the dynamic binding process, weak 
binding affinity and sample limitation. We have 
applied saturation transfer difference (STD) NMR, 
a widely used NMR technique, to facilitate the 
exploration of low affinity protein-ligand 
interactions (10-8~10-3) due to the fact that it 
detects the signals from the ligands via saturation 
transfer between the protein protons and the ligand 
protons  (44).  Only small amounts of non-labeled 
proteins or macromolecules are required. As 
shown in Fig. 10a, we observed that an intense 
proton signal around downfield 7.2 ppm that 
increased upon addition of 1 mM L-Phe (green 
line), which corresponds to the characteristic 1H L-
Phe NMR spectrum. The three major peaks in the 
STD spectrum of L-Phe (red line) are from the 
protein signal from the ECD of CaSR. The STD-
AF signal obtained by integrating each peak was 
plotted against the L-Phe concentration and was 
further fitted to the Hill equation (Fig. 10 b and c). 
A lower STD-AF signal was observed from 
interaction of the amino acid, L-Asp, with the 
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protein (Fig. 10 e), which was correlated with the 
weaker capacity of L-Asp to activate the receptor 
compared with L-Phe in intact cells (12). These 
spectra provide direct evidence to support the 
earlier hypothesis that L-Phe can bind to the 
extracellular domain of the calcium-sensing 
receptor with a Kd at 10.2 mM and a Hill 
coefficient of 1.4 (Fig. 10 b and c). Quantification 
of the STD-AF signal indicated that the binding 
constant of L-Phe to the GnTI- CaSR ECD was 
decreased to 4.6 mM with a Hill coefficient of 1.8 
in the presence of 3.2 mM calcium, which is the 
calculated Kd of GnTI- CaSR ECD for calcium. 
We also demonstrated in the current study that 
addition of 10 mM L-Phe also decreased the Kds 
for the  binding of calcium to the 293-F ECD and 
the GnTI-ECD from 4.9 ± 0.3 mM to 3.2 ± 0.3 
mM and 5.4 ± 0.2 mM to 3.4 ± 0.3 mM, 
respectively (Fig. 4 c and d). These results suggest 
that the interaction between Ca2+ and the receptor 
may influence the binding between L-Phe and the 
CaSR ECD and vice versa (Fig. 10 c and d).  
DISCUSSION 
The secreted CaSR ECD variants maintain 
native-like structural properties: In the present 
study, we were able to purify CaSR ECDs from 
both a wild type mammalian expression host using 
293-F cells, to generate complex type N-glycan 
structures, as well as from the HEK293S (GnTI-) 
cell line to produce high mannose N-glycans on 
recombinant products. In both of the two host cell 
systems, the target proteins were secreted into the 
culture media due to the presence of a signal 
peptide at the beginning of the ECD sequence. We 
have performed several studies to support the 
conclusion that the secreted ECD variants with 
different types of glycosylation maintain their 
native structural and functional properties.   
First, the secreted ECD proteins containing either 
the complex or high mannose glycans both appear 
to form dimers in the culture medium (Fig 2) 
consistent with the fact that CaSR functions as a 
dimer on the cell surface (45).  
Second, the secreted recombinant CaSR ECD 
containing complex glycosylation is able to bind 
to RCA-I beads and is susceptible to cleavage with 
PNGase F. Similar data were obtained for the 
EndoF1 cleavage of the high mannose N-glycans 
from the ECD produced in HEK293S (GnTI-) cells 
under native conditions (Fig. 2f). The above 
evidence suggests that the secreted proteins from 
the mammalian cell lines maintain their 
glycosylated characteristics.  
Third, far UV CD analysis of the two glycosylated 
forms of CaSR suggests that both have similar 
secondary structure contents, with 52-58%  
helical contents and 17-25% -sheet contents. 
These results are consistent with the modeled 
structure based on mGluR1’s crystal structure 
(Table 1) (46,47). 
The well-formed tertiary structure with a 
hydrophobic core of the secreted ECD of CaSR 
was revealed by a Trp emission maximum at 332 
nm (Fig. 4). The highly stable ECD protein with 
complex type saccharides was able to maintain its 
secondary structure at high temperature (>90C), 
while the CaSR ECD with its high mannose 
glycans was slightly less stable, exhibiting 
cooperative thermal unfolding. Such strong 
thermal stability and unfolding behavior are likely 
due to the formation of a stable hydrophobic core 
and the existence of well-formed, multiple 
disulfide bonds in the CaSR ECD (48).  
Ca2+ directly interacts with the extracellular 
domain of CaSR: We have used various 
spectroscopic methods to demonstrate the 
capacities of Ca2+ and Phe to bind to the ECD 
variants of CaSR studied here (Figs 4, 5, 8, 9 and 
10). As summarized in Tables 2 and 3, both 
variants exhibit similar Ca2+-binding despite the 
different methods that were employed.  
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The Kds for the interactions of Ca2+ with the ECDs 
that were monitored by intrinsic Trp florescence 
were 4.9 ± 0.3 mM and 5.4 ± 0.2 mM for the 
ECDs from 293-F and GnTI- cells, respectively. 
The Kds based on ANS florescence enhancement 
were 3.8 ± 0.2 mM and 3.2 ± 0.1 mM for the 
ECDs from the same respective cell lines. The 
Ca2+-Kds based on Tb3+ competition in FRET 
analysis were 3.7 ± 0.2 mM and 2.4 ± 0.2 mM for 
293-F and GnTI- cells, respectively, and similar 
millimolar binding constants were determined 
from chemical shifts in NMR spectra. These data 
indicate that Ca2+ can bind to the ECD of CaSR 
with a Kd in the mM range and that the alterations 
in glycosylation do not significantly alter the 
binding of Ca2+ to the ECD.  
Functional studies of the CaSR in cells as well as 
our previous metal-binding studies using grafting 
approaches have demonstrated that the CaSR 
likely has multiple Ca2+-binding sites (49). The 
Hill coefficients of both the 293-F and GnTI- 
CaSR ECDs calculated from calcium-induced 
ANS spectral changes (2.3~2.6) were also in 
agreement with the multiple Ca2+-binding modes. 
However, the intrinsic tryptophan spectral changes 
during the Ca2+ titration indicated mono- to 
biphasic binding of Ca2+ to CaSR with Hill 
coefficients in the range of 1.4~1.6. The 
discrepancy might be attributed to differences in 
the principles underlying the experiments. 7 out of 
10 tryptophan residues in the CaSR ECD are 
predicted to be located in lobe 2. Of all of these 
ten Trp residues, two of them (Trp70 and Trp299) 
are within 10 Å of calcium-binding site 1. 
Although Trp208 is close to calcium-binding site 3 
(~ 10 Å) and Trp352 is nearby calcium--sites 4 and 
5 (< 10 Å), both of which are more than 20 Å from 
site 1. Thus, the “sampling” of site 1 by Trp 
fluorescence may be more efficient than that of the 
others because site 1 may produce signals arising 
from 2 Trp, while the other sites are only close to 
one Trp each. Future studies could utilize site-
directed mutagenesis of sites 1-5 to determine 
which one(s) contribute most to Ca2+-induced 
changes in Trp fluorescence and the other 
spectroscopic methods used here to assess Ca2+-
binding.  
In previous studies from our lab, CaSR ECD 
subdomain 1, which includes predicted Ca2+-
binding sites 1, 2 and 3, showed biphasic binding 
processes when titrated with Tb3+, while 
subdomain 2 (including Ca2+-binding site 2 and 3) 
and subdomain 3 (including Ca2+-binding site 4 
and 5) had monophasic responses to Tb3+. 
However, in the present studies, the Tb3+-
concentration response curve for the 293-F and 
GnTI- CaSR ECDs did not show observable 
cooperative binding. This could possibly be due to 
the fact that in the grafting approaches, the 
subdomains were not constrained by the additional 
structural conformations that might be present 
when they are in the intact ECD structure. 
Concomitantly, the CaSR ECDs had much 
stronger binding affinities for Tb3+ than Ca2+ with 
Kds at M range. Thus, the differences of ligand 
binding capacity between potentially weak metal-
binding sites may not be detected. Moreover, 
intensive FRET signals between Tb3+ and more 
than one Trp residue in the intact ECD, as for site 
1, might produce a strong signal that could 
obscure possible cooperativity among these metal 
binding sites. On the contrary, fitting the data from 
the ANS assay resulted in Hill coefficients of >2. 
These data indicate that the ANS assay may 
provide a more effective means of capturing both 
local and global conformational changes in CaSR 
ECDs resulting from Ca2+ interacting with 
multiple binding sites.  These results from the 
ANS assay are in accordance with the observed 
multiple binding states from NMR spectra as 
shown in Fig. 9. Thus the different methods used 
here to assess Ca2+-binding to the two forms of the 
ECD studied here may differ in their capacity to 
“capture” cooperativity between Ca2+-binding 
sites. This might be the result of differences in 
their capacities to detect and “sample” the various 
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predicted and other possible Ca2+-binding sites 
within the ECD to an equivalent extent. Studies in 
intact cells, in contrast, integrate the overall signal 
resulting from cooperative binding of Ca2+ to its 
various sites in the ECD and perhaps elsewhere.  
Dynamic interaction of L-Phe to CaSR: Several 
studies from our laboratory and others have shown 
that L-Phe potentiates intracellular Ca2+ 
oscillations and other responses using site-directed 
mutagenesis and functional studies with HEK293 
cells expressing the CaSR (12,24,27,50). In vivo 
studies suggest that a minimum of 1 mM calcium 
is required in extracellular buffers in order to 
detect the L-Phe-triggered changes in intracellular 
Ca2+ concentration (15). While the Phe binding 
site of CaSR has been proposed to be located on 
the ECD, direct binding of Phe to CaSR has never 
been reported.  In the present study we confirmed 
a direct interaction between the extracellular 
domain and this CaSR allosteric regulator in the 
absence of Ca2+ using the STD NMR techniques 
with a binding affinity of 10.1 mM and a Hill 
coefficient of 1.4. Since L-Phe activates CaSR 
though signaling pathways in addition to [Ca2+]i 
signaling, the difference between the binding 
constant of L-Phe determined here and its EC50 in 
intact cells might be attributable, at least in part, to 
the synergistic effect of multiple downstream 
effects in cells (15,51).  
L-Phe and Ca2+ mutually facilitated each other’s 
interaction with the CaSR ECD. Several studies 
in intact cells have revealed that the EC50s of 
CaSR for binding of extracellular Ca2+ could be 
reduced from 4.0 mM to 2.5 mM in the presence 
of L-Phe (12,24). Here, we demonstrated that L-
Phe also increased the binding affinity of Ca2+ to 
the CaSR ECD measured directly using 
spectroscopic methods. Namely, 10 mM L-Phe 
reduced the Kds for Ca2+-binding from 4.9 ± 0.3 
mM to 3.2 ± 0.3 mM for 293-F ECD and from 5.4 
± 0.2 mM to 3.4 ± 0.3 mM for GnTI- ECD (Fig. 4 
c and d).  
Meanwhile, the presence of Ca2+ also increased the 
binding affinity of L-Phe to CaSR ECD, reducing 
the Kd from 10.2 mM to 4.6 mM. Similarly, 
functional studies carried out by Conigrave et al. 
in intact cells demonstrated that the half-maximal 
effect of L-Phe (EC50) was 3.5 mM in the presence 
of Ca2+ (12). These results provide evidence that 
potentiation of the activity of CaSR by L-Phe is at 
least partially exerted through its direct interaction 
with the extracellular domain. The intensity of the 
L-Phe STD signal was decreased in the presence 
of Ca2+ compared to that in the absence of Ca2+. It 
is possible that the conformation of the ECD was 
altered upon binding Ca2+ so that it can better 
accommodate L-Phe. Thus, the proton signal from 
L-Phe was not reflected as a simple additive effect 
on the STD spectrum when Ca2+ was added in the 
system. It is also possible that the agonist-induced 
change in receptor conformation involves 
intermolecular reorientation of the receptor at the 
dimer interface.  In fact, in the case of the crystal 
structures of mGluR1(1EWT, 1EWK, 1ISR), 
binding of glutamate produced not only domain 
closure but also a small shift of an  helix at the 
dimer interface along with a substantial rotation 
around the axis between the two ECDs (52).  
Ligand- induced conformational changes of the 
ECD of CaSR: Ca2+-induced conformational 
changes in the intact CaSR ECD were observed in 
both fluorescence and NMR spectra. There are 
seven tryptophan residues on the ECD, and among 
these are four that are proposed to be on the 
molecular surface between lobes 1 and 2. As Ca2+ 
bound to the protein, the polarity surrounding the 
tryptophan residues increased leading to a 
decreased fluorescence signal from the emission 
spectra. On the other hand, the signal from the 
ANS spectrum increased upon titration of Ca2+ 
suggesting the presence of ligand-induced 
exposure of more hydrophobic regions of the 
protein to interact with the ANS probe. The 
increase in the Ca2+-induced ANS signal of the 
293-F CaSR ECD was larger than that observed 
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with the GnTI- CaSR ECD, which indicates that 
the glycans on the 293-F CaSR ECD might 
contribute to the changes in hydrophobicity of the 
protein triggered by Ca2+.    
Calcium-induced alterations in conformation were 
also monitored by NMR chemical shift changes 
using uniform 15N-Phe labeled 293-F CaSR ECD 
(Fig. 9).  Chemical shifts of several Phe residues 
displayed differential behavior upon addition of 
calcium, indicating alterations in the local 
environments around these Phe residues.  There 
are more than 30 phenylalanine residues in the 
ECD of CaSR; however, a limited number of 
peaks were detected using 900MHz NMR, which 
precluded further assignment. Currently, we are 
working on labeling and assignment strategies to 
enable further structural studies by high resolution 
NMR.  
The observed ligand-induced conformational 
changes of the CaSR ECD are fundamental initial 
signals that initiate intracellular signaling via 
multiple downstream molecules leading to the 
regulation of parathyroid hormone (PTH) 
secretion and numerous other biological processes. 
Such interactions likely to be shared by other 
members of family C of the GPCRs. Several 
research articles have reported ligand bound forms 
and unliganded forms of mGluRs, showing 
alterations in the bi-lobed protomer architecture 
between the active and resting status through the 
modulation of the dimeric interface through a 
packed -helical structure (47,52,53). Ligands 
stabilize mGluR1 in the active form by keeping 
the closed bi-lobed receptor structure as the 
dominant state in dynamic equilibrium (47). 
Interestingly, our previous work also elucidated a 
potential Ca2+-binding site adjacent to the 
glutamate -binding site located at the hinge region 
of the ECD of mGluR1(28). Overall, the present 
study correlates well with observations from in 
vivo studies in intact cells using an intracellular 
Ca2+ readout (24), and will provide further insights 
into the structural underpinnings of agonist-
induced functions of the CaSR. This work should 
also permit further studies to define the key 
residues on the receptor involved in the interaction 
with ligands, including cations (e.g. Ca2+), 
nutrients such as amino acids, as well as 
antibiotics. This information will be crucial to 
understanding how the CaSR responds to variety 
of stimuli and may pave the way for future studies 
of other members of family C of the GPCRs. 
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Figure legends 
Fig. 1 Schematic representation of extracellular domain of the CaSR. (a) The first 26 amino acids are 
a signal sequence present in the vector. The arrow indicates the beginning of the CaSR ECD sequence. 
The stop codon is introduced immedaitely after residue 612, resulting in secretion of the receptor into the 
cell culture medium. Putative glycosylation sites are hightlighted using branches. The loop inserted 
between D371 and T372 is the engineered Flag-tag. Underlined and labeled regions represent peptide 
sequences that can be recognized by peptide-specific monoclonal antibody ADD. (b) Schematic figure of 
protein expression experiment design using 293-F and HEK293S(GnTI-) cells. (c) Model structure of 
CaSR ECD based on the mGluR1 crystal structure (PDB entry: 1ISR) was generated using Swiss-Model. 
The global view of the ECD is shown in the left panel. Spheres highlighted in red: Ca2+; Green: residues 
involved in predicted Ca2+-binding sites; Violet: locations of tryptophan residues. L-phenylalanine (in 
yellow) was positioned at the hinge region between the two lobes by Autodock Vina. Right bottom panel: 
A zoomed in view of the site 1 Ca2+-binding pocket. Residues involved in Ca2+-binding site 1 are 
highlighted in green. 
 
Fig. 2 CaSR ECD proteins isolated from cell culture medium are glycosylated 
(a) 293-F cells transfected with plasmid encoding 293-F CaSR ECD sequence were continuously cultured 
for 6 days. Then cell culture medium was collected and underwent the protein purification procedure 
using nickel affinity column. Representative tracing of A280 measured in milliAU for protein eluted by 
imidazole. Inset: Coomassie blue staining of the representative fractions from the affinity column 
separation. The lanes marked “M” are protein molecular weight standards. (b) The same chromatography 
of protein purification using secreted proteins from HEK293S (GnTI-) cells transfected with the CaSR 
ECD.  (c) 293-F CaSR ECD proteins (50 μg) from indicated fractions were heated at 100°C in sample 
buffer containing β-mercaptoethanol for 5 mins before loading on the gels. (d) GnTI- CaSR ECD proteins 
were treated using the aforementioned methods in (c). (e) Left two lanes were loaded with 293-F/GnTI- 
CaSR ECD incubated at room temperature for 5 mins in sample dissociation buffer without reducing 
reagent; right two lanes were loaded with 293-F/GnTI- CaSR ECD boiled for 5 mins in sample 
dissociation buffer with β-mercaptoethanol. (f) 293-F CaSR ECD protein (0.5 mg) was incubated with 
RCA-1 lectin agarose beads overnight at 4°C followed by a washing step with PBS. Lane 1: Elution 
fraction using PBS without addition of galactose. Lane 2:  Elution fraction using PBS containing 200 mM 
galactose. Lane 3: 5 l of the RCA-1 lectin agarose beads after incubation with protein were loaded into 
the gel as a positive control. The elution fractions were further analyzed by immunoblot using anti-flag 
antibody. (g) Purified 293-F CaSR ECD (20 g) was incubated at 100°C for 5 min to denature the protein 
followed by treatment with PNGase F for 2 hours at 37℃. Protein aliquots with or without PNGase F 
were loaded in the reducing SDS-Page gel and further analyzed by Western blot using an anti-flag 
antibody. (h) The purified GnTI--CaSR-ECD protein was mixed with Endo F1 at mass ratio 1:3 in 10 mM 
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Tris buffer, pH 7.4 with overnight shaking at 4 ℃. Samples were detected using anti-flag antibody by 
immunoblot under reducing conditions.  
 
Fig. 3 The secondary structure and stability of purified ECDs. (a) Far-UV CD spectrum of 293-F 
CaSR ECD in 10 mM Tris, pH 7.2 with or without 2.0 mM Ca2+, at 25 ℃. (b) Far-UV CD spectrum of 
GnTI- CaSR ECD in 10 mM Tris, pH 7.2 with or without 2.0 mM Ca2+, at 25 ℃. (c) Temperature 
dependence of the molar ellipticity at 222 nm for 293-F CaSR ECD (closed circle) and GnTI- CaSR ECD 
(open circle) in 10 mM Tris, pH 7.2. (d) The purified 293-F CaSR ECD protein aliquots were incubated 
in 10 mM Tris buffer (pH 7.2) at room temperature for the indicated number of days. Samples were then 
mixed with loading buffer with or without β-mercaptoethanol before being applied in the gel. R: without 
β-mercaptoethanol.  (e) The same experiment as in (d) but with GnTI- CaSR ECD. 
  
Fig. 4 Tryptophan fluorescence titration of CaSR ECDs. The calcium titration was performed in 
buffer system (10 mM HEPES, 120 mM NaCl and 10 mM KCl, pH 7.2) with a protein concentration of 
1.5~2.0 M. (a) Trp fluorescence spectra of 293-F CaSR ECD in the presence of 0 (---) and 15 mM Ca2+ (
—). (b) Trp fluorescence spectra of GnTI- CaSR ECD in the presence of 0 (---) or 15 mM Ca2+ (—). (c) 
Calcium titration curve of 293-F CaSR ECD (closed circle: without L-Phe; open circle: in the presence of 
10 mM L-Phe). (d) Calcium titration curve of GnTI- CaSR ECD (closed circle: without L-Phe; open 
circle: in the presence of 10 mM L-Phe).  
 
Fig. 5 Ca2+-induced changes in ANS fluorescence in CaSR ECDs. The ANS assay was performed in a 
buffer containing 40 M ANS, 50 mM Tris-HCl and 100 mM KCl (pH 7.4) with either 5 mM EGTA or 3 
mM Ca2+. The excitation wavelength was set at 370 nm, and the emission spectra were acquired from 400 
to 600 nm. The left panels show ANS fluorescence spectra of CaSR ECD in the presence (—) or the 
absence of (---) 12 mM Ca2+. The spectrum of ANS alone is shown in gray. The right panels show the 
calcium titration curve fitted by Hill equation. (a) 293-F CaSR ECD; (b) GnTI- CaSR ECD.  
 
Fig. 6 Tb3+ titration curve of CaSR ECDs. Tb3+ titration curves of purified CaSR ECDs. The buffer for 
Tb3+ titration consisted of 20 mM PIPES, 135 mM NaCl, and 10 mM KCl (pH 6.8). A pH 6.8 was chosen 
to prevent formation of TbOH3 during titration. The arrow indicates the increase of the fluorescence. The 
titration curve was fitted using Hill equation. (a) 293-F CaSR ECD; (b) GnTI- CaSR ECD.  
 
Fig. 7 Tb3+ competition assay of CaSR ECDs. Tb3+-Ca2+ competition assay of purified CaSR ECDs. 
The buffer for Tb3+ titration consisted of 20 mM PIPES, 135 mM NaCl, and 10 mM KCl (pH 6.8). The 
arrow indicates the decrease of the fluorescence. (a) 293-F CaSR ECD; (b) GnTI- CaSR ECD.  
 
Fig. 8 Ca2+ titration of CaSR ECD monitored by 1H NMR. 1H NMR spectra of CaSR ECDs in D2O 
and a solution of 10 mM Tris, pH 7.4. Ca2+-induced chemical shift changes in 293-F CaSR ECD were 
observed at resonances in the main chain amide proton region, such as 7.7 and 7.0 ppm.   
 
Fig. 9 (1H,15N)-HSQC spectra of 293-F CaSR ECD.  The (1H,15N)-HSQC spectra of CaSR ECDs was 
obtained in D2O and a solution of 10 mM Tris, pH 7.4.  Left panel: Ca2+-induced chemical shift changes 
of 293-F CaSR ECD. Red: 293-F CaSR ECD without addition of Ca2+; Orange, 1 mM Ca2+; Yellow, 3 
mM Ca2+; Green, 5 mM Ca2+; Cyan, 10 mM Ca2+. Middle panel: zoomed in view of each peak. Right 
panel: the normalized chemical shifts from peak b and c were plotted against calcium concentration and 
further fitted by the Hill equation.  
 
Fig. 10 Monitoring the ligand-protein interaction via STD NMR. (a) 1H NMR spectra of a solution of 
20 M GnTI- CaSR ECD in D2O and 10 mM of Tris (pH 7.8) without (blue line) or with (green line) 1 
mM of L-Phe. The difference between spectra at on and off resonance (STD) was shown in red line. The 
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region with the highlighted red box is zoomed in for further analysis in Fig. 10 b, c, and d. (b) Difference 
between spectra at on and off resonances upon binding of L-Phe at a series of concentrations. The 
integration of individual peaks was calculated during the L-Phe titration and further used for calculation 
of the STD amplification factor (STD-AF) in Fig.10 c & d. (c) The average STD-AF from the integrated 
signal of three major peaks was calculated using equation 
][
][
P
L
I
II
AFSTD T
ref
satref


  during L-Phe 
titration, and was further plotted against increased L-Phe concentration and further fitted using the Hill 
equation (open circle: without 3.2 mM Ca2+; closed circle: with 3.2 mM Ca2+).  (d) Upper panel: The STD 
signal spectra of 5 mM L-Phe in the presence of 20 M of GnTI- CaSR ECD with (Blue) or without 3.2 
mM Ca2+ (Red). Lower panel: The STD signal spectra of 3 mM L-Asp in the presence of 2.5 mM Ca2+ or 
in the absence of Ca2+. 
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Table 1. Secondary structure of CaSR ECDs at 25°C. 
 
-Helix 
 
-Strands 
 
Turns 
 
Unordered 
 
Without 
Ca2+ 
With Ca2+ 
 
Without 
Ca2+ 
With Ca2+ 
 
Without 
Ca2+ 
With 
Ca2+  
Without 
Ca2+ 
With Ca2+ 
293-F 
ECD 
58% ± 1% 55% ± 6% 
 
17% ± 1% 21% ± 4% 
 
6% ± 2% 5% ± 1% 
 
18% ± 4% 15% ± 4% 
GnTI- 
ECD 
52% ± 5% 60%  ±4% 
 
25% ± 3% 18% ± 1% 
 
5% ± 1% 7% ± 2% 
 
18% ± 3% 18% ± 3% 
Modeled 
ECD 
30.0% 
 
17.8% 
 
52.2% 
 
The signal from CD spectra was further deconvoluted using programs SELCON, CONTIN and CDSSTR. The average numbers of the secondary 
structure calculations are shown in the table.  
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Table 2. Summary of dissociation constants and Hill coefficients for CaSR ECDs.  
Proteins  
Trp Spectrum 
 
ANS Spectrum 
Kd (mM)      Hill number 
 Kd (mM)         Hill number 
(With 10 mM L-Phe) 
 
Kd (mM)         Hill number 
293-F ECD 4.9 ± 0.3 1.4 ± 0.1 3.2 ± 0.1* 1.2 ± 0.1  3.8 ± 0.2 2.6 ± 0.2 
GnTI- ECD 5.4 ± 0.2 1.6 ± 0.1 3.4 ± 0.3* 1.1 ± 0.1  3.2 ± 0.1 2.3 ± 0.2 
*p<0.05 
 
Table 3.  Summary of the Tb3+ FRET assay. 
Proteins 
Tb3+ Titration   Kd,Ca (mM) from Tb3+ 
Competition (M) 
Kd (M)       Hill number  Kd (mM)       Hill number 
293-F ECD  36.6 ± 0.4 1.2 ± 0.1 
 
3.7 ± 0.2 1.8 ± 0.1 
GnTI- ECD 31.8 ± 0.3 1.3 ± 0.2 
 
2.4 ± 0.2 1.6 ± 0.1 
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Fig. 1 
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 Fig. 2 
  
 
 
 
 
 
 at G
EO
RG
IA
 STA
TE U
N
IV
 on Septem
ber 23, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 
 
 23 
Fig. 3 
 
Fig. 4 
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Fig. 5 
 
Fig. 6 
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Fig. 7 
 
 
Fig. 8 
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Fig. 9 
 
Fig. 10 
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